Latest stories

  • As Expected, Big Pharma Wants Every Dime You’re Worth To Receive COVID Drug Remdesivir


    Gilead Sciences Inc. GILD +1.43% detailed its pricing plans for Covid-19 drug remdesivir, saying it will charge U.S. hospitals $3,120 for a typical patient with commercial insurance. The drugmaker on Monday disclosed its pricing plans as it prepares to begin charging for the drug in July. The U.S. has been distributing remdesivir donated by Gilead since the drug was authorized […] More

  • President Trump Announces FDA Approved New Drug To Battle Emergency Cases Of Coronavirus


    President Trump just announced that Remdesivir has been approved by the FDA for emergency applications relating to coronavirus: Gilead Sciences Inc.’s antiviral drug has been cleared by U.S. regulators for emergency use in Covid-19 patients, President Donald Trump told reporters at the White House Friday. The drug, Breaking! Trump announces FDA has approved drug for emergency use […] More